This has only happened a handful of times (it could've made you a fortune)

Unprecedented is an understatement

You are receiving this as part of your free subscription to Money Morning Profit Alerts. To remove your email from this list, unsubscribe here.

Editor's Note: My colleague Michael Robinson is reaching out today to spread news of an important FDA announcement to his readers. On September 20, a groundbreaking, lifesaving technology is expected to go live - and early investors could make an absolute killing. You'll want to see this right away... A Radical New Discovery Could Soon Be the Gold Standard Dear Profit Alerts Member, CRITICAL: The FDA just went public with an earth-shattering announcement. In less than two months from now, a revolutionary medical technology is expected to be unleashed... And it has the power to save two million lives. A moment like this in medicine only happens once in a blue moon... Like when Pfizer created Lipitor - helping their stock price soar 9,650%... Or when Gilead Sciences created Advair - helping lead to 12,372% gains... Or when Bristol-Myers created Plavix - helping lead to 8,146% gains. And we have every reason to believe this is going to happen again. (See how you can prepare yourself here.) This extraordinary discovery is already helping save the lives of U.S. soldiers... cancer patients... even infants with life-threatening conditions... Which means it could soon become as well-known as Aspirin. In other words, YOU could be behind the next big pharmaceutical disruption... Especially once you know the name of the ONLY company with FDA approval to use this. I'll show you everything you need to know - just click here. Sincerely, Michael Robinson Director of Technology and Venture Capital Research, Money Morning To unsubscribe from Money Morning Profit Alerts emails click here. © 2019 Money Morning All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any recommendations in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Money Morning. 1125 N Charles Street, Baltimore MD 21201. To read our privacy policy click here. To contact Customer Service click here.